Your browser doesn't support javascript.
loading
Signaling through the type 2 cannabinoid receptor regulates the severity of acute and chronic graft-versus-host disease.
Yuan, Cheng Yin; Zhou, Vivian; Sauber, Garrett; Stollenwerk, Todd; Komorowski, Richard; López, Alicia; Tolón, Rosa María; Romero, Julian; Hillard, Cecilia J; Drobyski, William R.
Affiliation
  • Yuan CY; Department of Microbiology.
  • Zhou V; Department of Medicine.
  • Sauber G; Department of Pharmacology and Toxicology, and.
  • Stollenwerk T; Department of Pharmacology and Toxicology, and.
  • Komorowski R; Department of Pathology, Medical College of Wisconsin, Milwaukee, WI; and.
  • López A; Faculty of Experimental Sciences, Universidad Francisco de Vitoria, Madrid, Spain.
  • Tolón RM; Faculty of Experimental Sciences, Universidad Francisco de Vitoria, Madrid, Spain.
  • Romero J; Faculty of Experimental Sciences, Universidad Francisco de Vitoria, Madrid, Spain.
  • Hillard CJ; Department of Pharmacology and Toxicology, and.
  • Drobyski WR; Department of Microbiology.
Blood ; 137(9): 1241-1255, 2021 03 04.
Article in En | MEDLINE | ID: mdl-33027805
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Signal Transduction / Receptor, Cannabinoid, CB2 / Graft vs Host Disease Type of study: Prognostic_studies Limits: Animals Language: En Journal: Blood Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Signal Transduction / Receptor, Cannabinoid, CB2 / Graft vs Host Disease Type of study: Prognostic_studies Limits: Animals Language: En Journal: Blood Year: 2021 Type: Article